Showing results (111-120 of 156) with videos related to

Sort By:
Pageof 16
Cancer Research and Treatment|March 13, 2015
Randomized Phase II Study of Pemetrexed Versus Gefitinib in Previously Treated Patients with Advanced Non-small Cell Lung CancerYoung Saing Kim, Eun Kyung Cho, Hyun Sun Woo, et al.
Molecular Plant|August 2, 2022
A potato late blight resistance gene protects against multiple Phytophthora species by recognizing a broadly conserved RXLR-WY effectorXiao Lin, Andrea Olave-Achury, Robert Heal, et al.
JAMA Network Open|January 6, 2026
Racial and Ethnic Disparities in Persistent Chemotherapy-Induced Alopecia Among Women With Breast CancerDanbee Kang, Lukas Kraehenbuehl, Haseen Lee, et al.
World Journal of Gastroenterology|February 17, 2015
Retrospective analysis of extra-gastrointestinal stromal tumorsJun Ho Yi, Byeong-Bae Park, Jung Hun Kang, et al.
Lung Cancer (Amsterdam, Netherlands)|November 7, 2025
Phase II study of lazertinib and pemetrexed in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer with leptomeningeal metastases: the KCSG LU 21-01, LAZARUS studyHyun Ae Jung, Tae Min Kim, Hye Ryun Kim, et al.
Cancer Research and Treatment|February 4, 2021
Recent Treatment Patterns of Oropharyngeal Cancer in Korea Based on the Expert Questionnaire Survey of the Korean Society for Head and Neck Oncology (KSHNO)Kyu Hye Choi, Jin Ho Song, Yeon-Sil Kim, et al.
The Oncologist|March 11, 2022
Tyrosine Kinase Inhibitor Activity in Patients with NSCLC Harboring Uncommon EGFR Mutations: A Retrospective International Cohort Study (UpSwinG)Sanjay Popat, Te-Chun Hsia, Jen-Yu Hung, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 11, 2025
Lazertinib for Patients with NSCLC Harboring Uncommon EGFR Mutations: A Phase II Multicenter TrialSehhoon Park, Hee Kyung Ahn, Seoyoung Lee, et al.
Lung Cancer (Amsterdam, Netherlands)|February 23, 2025
Delayed central nervous system progression with atezolizumab plus chemotherapy in extensive-stage small-cell lung cancer (LU23-15)Kyoungmin Lee, Tae-Hwan Kim, Sung Yong Lee, et al.
Neuro-Oncology|June 14, 2012
Prediction of outcomes for patients with brain parenchymal metastases from breast cancer (BC): a new BC-specific prognostic model and a nomogramHee Kyung Ahn, Soohyeon Lee, Yeon Hee Park, et al.
Pageof 16